These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7514323)

  • 1. [Immunophenotyping in chronic B-cell lymphatic leukemia].
    Kopecký O; Krejsek J; Voglová J; Derner V
    Vnitr Lek; 1994 Mar; 40(3):145-50. PubMed ID: 7514323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of the expression of the C6 molecule on cells in chronic lymphatic leukemia].
    Krejsek J; Kopecký O; Derner V; Voglová J
    Vnitr Lek; 1996 Apr; 42(4):274-7. PubMed ID: 8693715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
    Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL).
    Faguet GB; Marti GE; Agee JF; Bertin P
    Ann N Y Acad Sci; 1992 May; 651():470-3. PubMed ID: 1376063
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
    Scrivener S; Kaminski ER; Demaine A; Prentice AG
    Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia.
    Espinosa A; Bjørk P; Magnussen K; Moen T; Sørum Y
    Leuk Lymphoma; 2003 Jan; 44(1):193-6. PubMed ID: 12691163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
    Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
    Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of immunophenotype, lymphocytic subsets and NK cells in patients with B cell chronic lymphoid leukemia].
    Zhang L; Zhu L; Wang HW; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):36-9. PubMed ID: 19236743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
    Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
    Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
    Roliński J; Rupniewska ZM; Wasik-Szczepanek E
    Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of surface immunoglobulin, mouse rosettes, and CD5 in the immunophenotyping of chronic lymphocytic leukemia and reactive lymphocytosis.
    Batata A; Shen B
    Cancer; 1991 Jul; 68(2):355-61. PubMed ID: 2070335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
    Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
    Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
    Maruyama S
    Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocyte subpopulations determined by flow cytometry in chronic type B lymphatic leukemia].
    Kvasnicka J; Kruzík P; Cmunt E; Neurwirtová R
    Cas Lek Cesk; 1994 Aug; 133(16):506-10. PubMed ID: 7923329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of HLA-DR expression in a patient with B-chronic lymphocytic leukemia.
    Vartholomatos G; Kapsali E; Dokou E; Bourantas KL
    J Exp Clin Cancer Res; 2001 Jun; 20(2):305-6. PubMed ID: 11484993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.